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Ethnopharmacological relevance: Hyptis fruticosa is a plant native to Brazil with antinociceptive and
antiinﬂamatory properties. This study evaluated the antinociceptive activity of the hydroethanol
extract of the plant leaves (CHEE) against orofacial pain as well as its in vitro effect against lipid
peroxidation.
Materials and methods: The antinociceptive activity was investigated in mice orally treated with
different doses of the CHEE (50, 100, and 200 mg/kg) and morphine (5 mg/kg) using formalin,
glutamate, and capsaicin orofacial pain models using. Lipoperoxidation was induced in egg yolk by
AAPH and FeSO4 in the absence and presence of the CHEE (5, 50, 100, and 150 mg/mL).
Results: CHEE (200 mg/kg) signiﬁcantly reduced (ro0.001) the pain response in the ﬁrst (69.6%) and
second (81.8%) phases of the formalin test, while the nociception caused by capsaicin was signiﬁcantly
(ro0.001) reduced by up to 62% at 200 mg/kg of extract. When glutamate was used as algogen,
a signiﬁcant (ro0.001) nociception reduction of up to 85% at 200 mg/kg extract was observed. CHEE
showed a higher protection against lipoperoxidation caused by FeSO4 (82.3% TBARS inhibition) than
AAPH (35.7% TBARS inhibition) at 150 mg/mL.
Conclusion: Hyptis fruticosa leaf CHEE is of pharmacological interest because it was able to inhibit the
peripheral and central transmission of orofacial pain, while reducing the spreading of the inﬂammatory
processes by neutralizing reactive oxygen species, which are by-products in the biosynthesis of pain
mediators.
& 2013 Elsevier Ireland Ltd. Open access under the Elsevier OA license. 1. Introduction
Pain is a complex multidimensional phenomenon linked to
nociception recognition, which can be deﬁned as the perception
of a lesion in tissues. It is controlled by a receptor system that
sends information to the brain through specialized nervous ﬁbers
(Heredia and Rodrigues, 2008; Szumita et al., 2010). In this
context, the orofacial region is a common part of the body for
pain to occur, which is acute and frequently associated with
respiratory, head, and neck syndromes (Macfarlane et al., 2001;
Luccarini et al., 2006; Bonjardim et al., 2011). Despite its impor-
tance, the mechanisms by which the orofacial pain occurs are still
poorly understood, probably due to few animal models to study
nociception in this area (Bonjardim et al., 2011). In addition, there
are difﬁculties in treating both acute and chronic orofacial pain7.
r the Elsevier OA license. when they are caused by neuropeptides or leukotrienes because
nonsteroidal anti-inﬂammatory drugs (NSAIDs) are not effective
in inhibiting these inﬂammatory mediators (Lindenmeyer et al.,
2010). Therefore, the development of alternative therapies is
necessary.
Hyptis fructicosa (Lamiaceae) is known as ‘‘alecrim de
tabuleiro’’ and can be found in the coastal tablelands and low-
lands of northeast Brazil, where it is an important medicinal plant
whose leaves are directly chewed or the leaf tea is used by the
population to treat pain (Menezes et al., 2007; Agra et al., 2008;
Franco et al., 2011). Hyptis fruticosa has been the subject of some
studies, which reported the toxicities of the essential oil and leaf
aqueous extract, antibacterial and antineoplasic activities of
compounds isolated from the plant roots, and cardiovascular
effects of the essential oil (Silva et al., 2006; Menezes et al.,
2007; Santos et al., 2007). Regarding pain and inﬂammation, the
analgesic and antinociceptive activities of the Hyptis fruticosa
essential oil and leaf aqueous extract were also demonstrated
(Menezes et al., 2007; Franco et al., 2011). Nevertheless, despite of
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demonstrate its effect on the orofacial pain. Therefore, the present
study aims to improve the knowledge of the antinociceptive
activity of this plant by studying its potential to treat orofacial
pain using formalin, glutamate, and capsaicin pain models, as well
as its possible antioxidant and anti-lipoperoxidative activity.2. Materials and methods
2.1. Plant material
Hyptis fruticosa Salzm. Ex Benth. leaves were collected in July
2009, in the village Beans, S~ao Cristo´v~ao, Sergipe (101 56’S, 371
05’W). The plant was identiﬁed by Profa. Dra. Ana Paula Silver,
botanist of the Department of Biology, Federal University of
Sergipe, Brazil (DB–UFS). A voucher specimen was deposited in
the Herbarium of the DB–UFS under the registration number
SEA 13649.2.2. Extract preparation
Leaves were dried at environment temperature and triturated
in a knife mill to give a ﬁne powder (900.5 g), which was
subjected to extraction bymaceration with 90% ethanol for 7 days.
The extract was concentrated by solvent evaporation in a rotary
evaporator under reduced pressure to give the crude hydroetha-
nol extract (CHEE, 381.3 g, yield 42.3%).2.3. Phytochemical analysis
The qualitative identiﬁcation of the main classes of the
secondary metabolites presents in the CHEE was done by using
the colorimetric methods (Table 1) proposed by Sousa et al.
(2007) and Matos (2009).2.4. Total phenol quantiﬁcation
The total phenol content was spectrophotometrically deter-
mined using the Folin–Ciocalteu method (Sousa et al., 2007).
The reaction mixture was composed of extract (0.1 mL), distilled
water (7.9 mL), Folin–Ciocalteu reagent (0.5 mL), and 20% sodium
carbonate (1.5 mL). After 2 h, the absorbance of the resulting
solutions was measured at 750 nm and applied in the calibration
curve built with known concentrations of gallic acid (GA) stan-
dards (0.01 to 0.35 mg/mL). Results were expressed as milligram
equivalents of gallic acid per g of extract (EAG mg/g). All analyses
were carried out in triplicate.Table 1
Phytochemical analysis of the crude methanol extract of Hyptis fructicosa leaves
and its fractions.
Metabolites Assays CHEE
Alkaloids Mayer’s reagent/Dragendorff’s reagent 
Phenols in general Folin Ciocaultey reagent þ
Flavonoids in general Hydrochloric acid/magnesium þ
Flavones pH change þ
Flavononols pH change þ
Tannins Cerric sulphate þ
Saponins Clorofo´rmio þ
Steroids Lieberman–Bouchard’s reagent þ
Triterpenes Anysaldehyde/Sulfuric acid þ
Xanthones pH change þ2.5. In vitro lipid peroxidation inhibitory activity
The degree of lipid peroxidation prevented by the hydroetha-
nol extract was monitored by measuring the production of
thiobarbituric acid-reactive substances (TBARS) (Budni et al.,
2007). Brieﬂy, egg yolk homogenate (1%w/v, 1 mL) in phosphate
buffer (pH 7.4) was sonicated (10 s) and mixed with freshly
prepared solutions of the hydroethanol extract and controls at
5, 50, 100 and 150 mg/mL. Lipid peroxidation was induced by
adding either 20-azobis(2-amidinopropane) dihydrochloride
(AAPH, 0.17 mol/L, 0.1 mL) or ferrous sulphate (FeSO4, 0.17 mol/
L, 0.1 mL). Trolox was used a positive control, while the negative
control was the vehicle (water or ethanol). The mixture was
incubated at 37 1C for 30 min. Upon cooling, samples (0.5 mL)
were centrifuged with 15% trichloroacetic acid (TCA, 0.5 mL) at
1200 rpm for 10 min. Supernatant was taken (0.5 mL), mixed with
0.67% thiobarbituric acid (TBA, 0.5 mL), incubated at 95 1C for
60 min and, after cooling, the formation of TBARS was measured
by reading the supernatant absorbance at 532 nm. Results were
expressed as inhibition percentage of TBARS formation.
2.6. Antinociceptive activity
2.6.1. Animals
Male Swiss mice weighing 20–35 g each, obtained from the
Central Animal House of the Federal University of Sergipe, were
randomly maintained in cages under controlled temperature
(2273 1C) with light/dark cycles of 12 h (lights on from 06h00
to 18h00). The animals had free access to food (PurinaTM) and tap
water. Animal Care and Use Committee of Federal University of
Sergipe approved the experimental protocols and procedures
under the registration CEPA/UFS number 65/09.
2.6.2. Formalin test
Orofacial nociception was induced in mice by injection of 2%
formalin (20 mL, s.c) in the right upper lip (perinasal area) using a
27-gauge needle (Luccarini et al., 2006). The volume and formalin
concentration were selected from pilot studies that showed a
nociceptive-related biphasic behavioral response of great inten-
sity at periods from 0 to 5 min (ﬁrst phase) and 15 to 40 min
(second phase). Nociception was quantiﬁed by measuring the
time (sec) animals spent rubbing their faces in the injected area
with their fore- or hind paws. To assess the effects of the test
drugs, groups of mice (n¼8) were systematically pretreated with
vehicle (one drop of 0.2% Tween 80 in distilled water) and CHEE
(50, 100, and 200 mg/kg, v.o.) 1 h before the formalin injection.
Morphine (MOR, 5 mg/kg, i.p.), administered 1 h before the
algogen, was included as positive control.
2.6.3. Capsaicin test
Orofacial nociception was induced by capsaicin (Pelissier et al.,
2002) as described for formalin. Capsaicin (20 mL, 2.5 mg, s.c.) was
injected in the perinasal area and the drug effects were evaluated
using the same groups as described previously, which were
administered 1 h before the algogen. Capsaicin was dissolved
in ethanol, dimethyl sulfoxide and distilled water (1:1:8), and
the face-rubbing behavior was observed during 42 min. MOR
(5 mg/kg, i.p.) was used as positive control.
2.6.4. Glutamate test
In an attempt to provide evidence of the CHEE interaction with
the glutamatergic system, its antagonistic effect on glutamate-
induced orofacial nociception in mice was studied using the
method previously described by Beirith et al. (2002) with mod-
iﬁcations. Glutamate (20 mL, 25 mmol/L in phosphate buffered
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were observed individually during 15 min. Nociception was
quantiﬁed by measuring the time (sec) the animals spent rubbing
the injected area with their fore- or hind paws. Animals in the
groups were injected with the CHEE, MOR or vehicle, as pre-
viously described for formalin, 1 h before the glutamate injection.2.7. Statistical analysis
Data obtained were evaluated by One-Way Analysis of
Variance (ANOVA) followed by Dunnett’s test for mean differences
to be considered statistically signiﬁcant (ro0.05).3. Results
The phytochemical screening of the Hyptis fruticosa CHEE,
whose results are shown in Table 1, revealed the presence of
two main classes of secondary metabolites: phenolic compounds
and terpenes. The total phenol concentration determined for the
CHEE was 360.51716.29 EGA mg/g extract.Fig. 1. Effect of Hyptis pectinata CHEE on the amount of TBARS (Thiobarbituric
Acid-Reactive Substances) produced in the presence of the free radical inducers
FeSO4 (A) and AAPH (B). The effect of different concentrations of the CHEE and the
standard antioxidant Trolox in preventing egg yolk lipoperoxidation were spectro-
photometrically measured at 532 nm. Bars represent mean7SEM. nnnPo0.001,
when compared to control. One-way ANOVA followed by Dunnett’s post hoc test
was applied to all data.In the present study, in vitro lipoperoxidation of egg yolk was
induced by two chemical substances, AAPH and FeSO4, to study
the antioxidant effect of the CHEE against lipid oxidation.
In presence of FeSO4, the extract showed a high protection against
lipoperoxidation with inhibition of the TBARS ranging from 71 to
83%. The highest inhibition (82.3%) was observed at 150 mg/mL
(Fig. 1A). When the lipoperoxidation was induced by the AAPH, its
inhibition varied from 16 to 36% and the highest value was
observed at 150 mg/mL (Fig. 1B). However, lipoperoxidation
inhibition was signiﬁcantly (ro0.01, ro0.001, respectively)
lower than the controls for both inducers (Fig. 1A and B).
The effect of CHEE on the nociception induced by formalin,
which was characterized by the reduction of the face rubbing
time after the chemical stimulus, is shown in Fig. 2. The extract in
all doses used signiﬁcantly reduced (ro0.001) pain response in
both phases of the test in comparison with the control as follow:
37.7%, 38.1%, and 69.6% (ﬁrst phase) and 61.9%, 74.3%, and 81.8%
(second phase) for 50, 100, and 200 mg/kg, respectively.Fig. 2. Antinociceptive effect of Hyptis fruticosa CHEE at different concentrations
and morphine (MOR) in the pain response induced during the ﬁrst (A) and second
(B) phases of the formalin test. Orofacial nociception was induced in mice by
injecting 2% formalin in the right upper lip with a needle and quantiﬁed by
measuring the time (sec) animals spent rubbing their faces in the injected area
with their fore- or hind paws. Bars represent mean7SEM. nnPo0.01 and
nnnPo0.001, when compared to control. One-way ANOVA followed by Dunnett’s
post hoc test was applied to all data.
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dose-dependent manner by CHEE at 100 mg/kg and higher doses.
A dose-dependent antinociceptive effect was observed when
capsaicin was used as a nociceptive inducer (Fig. 3A), with
inhibition of mice face rubbing varying from 14 to 62%, which
was signiﬁcant at doses of 100 (ro0.01) and 200 (ro0.001) mg/
kg of extract. As shown in Fig. 3B, when the Hyptis fruticosa CHEE
was administered orally to mice, it caused a dose-dependent
inhibition of the glutamate-induced nociception by reducing mice
face rubbing from 43 to 85%. In addition, all doses of the extract
showed a signiﬁcant reduction of the nociception (ro0.05,
ro0.01, ro0.001, respectively) caused by glutamate when
compared with the control. ED50 values for the extract were
76.07 and 150.63 mg/kg, respectively, for glutamatate and cap-
saicin antinociceptive tests.Fig. 3. Antinociceptive effect of Hyptis fruticosa CHEE at different concentrations
and morphine (MOR) in the pain response induced by 2.5 mg/kg capsaicin (A) and
25 mM glutamate (B) injection in right upper lip of mice with a needle. Nociception
was quantiﬁed by measuring the time (sec) animals spent rubbing their faces in
the injected area with their fore- or hind paws. Bars represent mean7SEM.
nPo0.05, nnPo0.01 and nnnPo0.001, when compared to control. One-way ANOVA
followed by Dunnett’s post hoc test was applied to all data.4. Discussion
Face sensory information is processed by the trigeminal nerve,
which is also related to motor activities such as biting, chewing,
and swallowing. This nerve is divided into three main branches
called the ophthalmic nerve (sensory), maxillary nerve (sensory),
and mandibular nerve (sensory and motor). The maxillary nerve
carries sensory information caused by chemical, thermal, and
mechanical stimulus from the lower eyelid and cheek, the nares
and upper lip, the upper teeth and gums, the nasal mucosa, the
palate and roof of the pharynx, the maxillary, ethmoid, and
sphenoid sinuses, and parts of the meninge, towards the central
nervous system, where the noxious stimuli are frequently
translated as orofacial pain. CHEE effect in preventing orofacial
pain caused by chemical stimulation of the maxillary nerve
in the upper lip of mice was investigated in the present since
the extract and essential oil of the plant previously showed
antinociceptive activity (Silva et al., 2006, Menezes et al., 2007;
Franco et al., 2011).
In the formalin orofacial test, an established pre-clinical model
to investigate the analgesic potential of substances on facial pain,
formaldehyde induces damages in tissues to imitate acute post-
lesion pain in humans with a biphasic response (Bonjardim et al.,
2011). In the acute phase, called neurogenic, nociception is caused
by direct activation of the nociceptive ﬁbers, which release
substance P, glutamate, and bradykinin, among other pain med-
iators (Luccarini et al., 2006; Bonjardim et al., 2011). The late
phase, which is inﬂammatory, is mediated by the release of
inﬂammatory mediators such as nitric oxide, excitatory amino
acids (aspartate and glutamate), prostacyclins and prostaglandins
(PGE2), and leukotrienes, which will later stimulate the spinal
cord and cause pain (Tjølsen et al., 1992; Bonjardim et al., 2011;
Venaˆncio et al., 2011). Results in the present study showed
the CHEE inhibited both nociceptive phases induced by formalin,
suggesting the extract has central and peripheral antinociceptive
activity, similarly to morphine, the standard drug used for
nociception.
The effect of CHEE on orofacial pain was further investigated
by the glutamate test. Glutamate, an excitatory amino acid, is
found primarily in Type C sensory ﬁbers and transmits nocicep-
tive information involving peripheral, spinal, and supraspinal
sites of action. (Beirith et al., 2002; Bonjardim et al., 2011).
Glutamate is released from afferent ﬁbers sensitized by nerve or
tissue injury or by response to noxious stimuli (Keast and
Stephensen, 2000; Lam et al., 2005). The main mechanisms used
by agonists of glutamate receptors to cause pain include the
intracellular release of Ca2þ , activation of cellular mediators, and
the opening of ion channels (Lipton and Rosenberg, 1994; Millan,
1999), which are associated with an increase in the production of
NO, protein kinase C activity, and calcium inﬂow (Liu et al., 1997;
Ji and Stricharstz, 2004). In addition, glutamate combined with
other mediators and pro-inﬂammatory cytokines (TNF-a and
IL-1b) act synergistically in neuronal excitation (Liu et al., 1997;
Millan, 1999; Bernardino et al., 2005). The results of the present
study showed that CHEE inhibited the nociception caused by
glutamate with signiﬁcant results for the highest concentration
used (200 mg/kg), suggesting that the extract can be active
against sensory information transport associated with this amino
acid. This may be related to the inhibition of glutamatergic
receptors such as N-methyl-D-aspartate (NMDA), kainate (KA)
and a-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA)
(Beirith et al., 2002).
Vanilloid receptors (TRPV1) are involved in orofacial nocicep-
tion by contributing to the integration and detection of chemical
and thermal stimulus in peripheral sensory neurons such as Type
C and Ad. These receptors can be activated by capsaicin, the
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acting selectively on sensory neurons to promote pain (Caterina and
Julius, 2001). TRPV1 activation by capsaicin will induce a cation
inﬂow to produce neuron depolarization and excitation (Pelissier
et al., 2002) so that neuropeptides such as tachykinins (neurokinin
A), substance P, calcitonin peptide, excitatory amino acids (aspartate
and glutamate), nitric oxide, and other pro-inﬂammatory substances
are released from peripheric terminals to transfer the painful
stimulus through the trigeminal nerve (ﬁfth cranial nerve) (Holzer,
1991; Waning et al., 2007; Honda et al., 2008). CHEE at 100
and 200 mg/kg was able to reduce the capsaicin nociceptive
effect, suggesting it is an antagonist of vanilloid receptors and
modulates the transfer of pain sensory information through the
trigeminal nerve.
During inﬂammatory processes, free radicals such as nitric oxide
and reactive oxygen species derived from the prostaglandin biosynth-
esis are released in the organism, where they will propagate pain and
inﬂammation by activating nociceptive receptors such as TRPV1 and
NMDA (Ma et al., 2009; Chen et al., 2010) and cause the oxidation of
membrane components such as lipids. This will damage the cell
membrane, its metabolism and create the conditions needed for the
establishment of free radical related diseases such as cancer and
diabetes (Wilhelm, 1990). Therefore, CHEE was investigated for its
action against lipid oxidation using the lipoperoxidative inducers
AAPH to generate peroxyl radicals able to remove hydrogen from
peroxidable lipids, and FeSO4 to generate hydrogen peroxide or
hydroxyl radicals, which cause lipid peroxidation and give lipid
alkoxyl radicals (Hanlo and Seybert, 1997; Budni et al., 2007;
Mendez-Sanchez et al., 2008). The results found in the present study
showed that the phenolics present in CHEE, as it was shown by the
colorimetric methods in Table 1 as well as the total phenol quanti-
ﬁcation, are able to reduce the peroxidation of lipids caused by
hydrogen peroxide and hydroxyl radicals, while they are less effective
against the peroxidation caused by peroxyl radicals. The selectivity for
certain types of free radicals is related to the hydroxyl groups in the
aromatic rings of phenolics. Hydroxyl groups can donate their
hydrogen to the free radical and the aromatic ring turned into a
radical itself is then stabilized by electron resonance. It was pointed
out the hydrogen donation and stabilization by resonance depend of
the position and number of hydroxyl as well as the number of
conjugated aromatic rings and/or double bonds so the free electron
can generate several resonance forms of the molecule. Therefore, the
higher the number of resonance forms the higher the probability of a
certain phenolic to scavenger free radicals (Van Acker et al., 1996;
Ainsworth and Gillespie, 2007; Budni et al., 2007).
In conclusion, the Hyptis fruticosa leaf CHEE at 100 and 200mg/kg
can be of pharmacological interest because it is not only able to
inhibit the peripheral and central transmission of orofacial pain, but
also shows potential in reducing the spreading of the inﬂammatory
processes by neutralizing reactive oxygen species, which are by-
products in the biosynthesis of pain mediators.Aknowledgments
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